www.illinois.gov

Pat Quinn, Governor

State Links Skip to Content Skip to State Links

 Government
 Business
 Employment
 Education
 Health & Safety
 Family & Home
 Travel & Recreation
 About Illinois
 Illinois.gov

Stay Informed

Your Government


Illinois Flag Honors

Inspector General


 IGNN: State/All Press Release

ILLINOIS NEWS
The State of Illinois News page provides access to the Illinois Government News Network and all state press releases.


FOR IMMEDIATE RELEASE
August 3, 1999

Governor Acts On Drug Review Panel Legislation

SPRINGFIELD - Gov. George H. Ryan today amendatorily vetoed legislation approved this spring that would have stripped a state panel of its authority to evaluate generic drugs to be substituted for name-brand drugs and clarified the group's role.

Ryan, a retired pharmacist, asked for legislative concurrence with his changes to House Bill 2256, which would narrow the Technical Advisory Council (TAC) review of generic name drugs to those determined to be "critical dose drugs" prior to allowing them to be substituted for brand-mane drugs.

"Through this action, I'm seeking to maintain an important protection for Illinois consumers," Ryan said. "I want to ensure that a subset of drugs whose margin of error is so small they could be life threatening will continue to receive close scrutiny."

Critical dose drugs require carefully measured amounts and routine monitoring of the patient, and exhibit a narrow margin between a lethal and effective dosage. There are about two dozen drugs on Illinois' drug formulary that would meet this definition and are used in the treatment of serious medical conditions, such as heart problems, epilepsy, diabetes, stroke and mental illness.

"Over the past 20 years, the Technical Advisory Council has competently performed the vital function of establishing safeguards to protect our citizens from the dangerous consequences of inappropriate switching of these highly sensitive medications," Ryan said.

The TAC was established in 1978 to evaluate generic drugs and is made up of a panel of volunteer doctors, pharmacists and pharmacologists appointed by the director of the Illinois Department of Public Health. Based on TAC recommendations, the Department publishes a Drug Production Selection Formulary that details for Illinois pharmacists those generic drugs that can be substituted for name brands.

While proponents of House Bill 2256 argued that TAC was costly and duplicated the U.S. Food and Drug Administration's (FDA) "Orange Book" of therapeutically-equivalent drugs, Ryan recounted examples of generic drugs approved by the FDA that later were determined unsafe by TAC.

They include phenylbutazone and oxyphenbutazone, anti-inflammatory agents that were found to have the ability to destroy bone marrow; cyclosporine, an immunosuppressent for organ transplants later was shown to have erratic absorption that could result in either toxicity or possible organ rejection; and warfarin sodium, a blood thinner that if taken in the slightest variation can be life-threatening.


###

News Categories

 State/All
 Governor's Office
 Lt. Governor's Office
 Agriculture
 Budget/Fiscal
 Business
 Children/Families
 Culture
 Disabilities
 Economic Development
 Education
 Environment
 Flag Honors
 Health/Human Services
 History
 Infrastructure
 Opportunity Returns
 Recovery
 Safety/Security
 Technology
 Tourism/Recreation
 Transportation
 Workforce/Jobs

News Resources

 Search the News
 IIS Radio News
 RSS News Feeds
 e-News Subscriptions
 Communications Office
 Privacy Statement

Features

Sign up for an e-news subscription
Copyright © 2014 State of Illinois Site Map | Illinois Privacy Info | Kids Privacy | Web Accessibility | Contact Us